Harry Jansen Kraemer Jr Buys 38,000 Shares of Option Care Health (NASDAQ:OPCH) Stock

Option Care Health, Inc. (NASDAQ:OPCH) Director Harry Jansen Kraemer, Jr. acquired 38,000 shares of the stock in a transaction on Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the transaction, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

Option Care Health Stock Performance

OPCH stock traded up $0.61 during trading hours on Tuesday, hitting $27.03. 3,154,529 shares of the stock were exchanged, compared to its average volume of 1,906,451. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $4.39 billion, a P/E ratio of 21.62, a P/E/G ratio of 1.74 and a beta of 0.88. The company has a 50-day simple moving average of $27.89 and a two-hundred day simple moving average of $29.83. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Thursday, October 30th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter last year, the business earned $0.41 EPS. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.680-1.720 EPS. On average, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently made changes to their positions in OPCH. GAMMA Investing LLC lifted its stake in shares of Option Care Health by 307.1% in the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock worth $112,000 after acquiring an additional 2,408 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Option Care Health by 25.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock valued at $289,000 after buying an additional 1,691 shares during the period. Teacher Retirement System of Texas lifted its stake in Option Care Health by 73.0% in the first quarter. Teacher Retirement System of Texas now owns 107,644 shares of the company’s stock valued at $3,762,000 after buying an additional 45,431 shares during the period. Principal Financial Group Inc. lifted its stake in Option Care Health by 1.4% in the first quarter. Principal Financial Group Inc. now owns 485,871 shares of the company’s stock valued at $16,981,000 after buying an additional 6,616 shares during the period. Finally, Penserra Capital Management LLC acquired a new position in Option Care Health in the first quarter valued at approximately $778,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OPCH has been the topic of a number of recent analyst reports. Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating on the stock. TD Cowen reduced their price objective on Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research note on Monday. Citizens Jmp reduced their price objective on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a research note on Friday. JMP Securities set a $36.00 price objective on Option Care Health in a research note on Friday. Finally, Morgan Stanley assumed coverage on Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective on the stock. Nine equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.67.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.